Cargando…
miR-34a: Multiple Opposing Targets and One Destiny in Hepatocellular Carcinoma
Background and Aims: The role of miR-34a in hepatocellular carcinoma (HCC) is controversial and several unresolved issues remain, including its expression pattern and relevance to tumor etiology, tumor stage and prognosis, and finally, its impact on apoptosis. Methods: miR-34a expression was assesse...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
XIA & HE Publishing Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5225149/ https://www.ncbi.nlm.nih.gov/pubmed/28097098 http://dx.doi.org/10.14218/JCTH.2016.00031 |
_version_ | 1782493462295216128 |
---|---|
author | Yacoub, Radwa Alaa Fawzy, Injie Omar Assal, Reem Amr Hosny, Karim Adel Zekri, Abdel-Rahman Nabawy Esmat, Gamal El Tayebi, Hend Mohamed Abdelaziz, Ahmed Ihab |
author_facet | Yacoub, Radwa Alaa Fawzy, Injie Omar Assal, Reem Amr Hosny, Karim Adel Zekri, Abdel-Rahman Nabawy Esmat, Gamal El Tayebi, Hend Mohamed Abdelaziz, Ahmed Ihab |
author_sort | Yacoub, Radwa Alaa |
collection | PubMed |
description | Background and Aims: The role of miR-34a in hepatocellular carcinoma (HCC) is controversial and several unresolved issues remain, including its expression pattern and relevance to tumor etiology, tumor stage and prognosis, and finally, its impact on apoptosis. Methods: miR-34a expression was assessed in hepatitis C virus (HCV)-induced non-metastatic HCC tissues by RT-Q-PCR. Huh-7 cells were transfected with miR-34a mimics and the impact of miR-34a was examined on 84 pro-apoptotic/anti-apoptotic genes using PCR array; its net effect was tested on cell viability via MTT assay. Results: miR-34a expression was up-regulated in HCC tissues. Moreover, miR-34a induced a large set of pro-apoptotic/anti-apoptotic genes, with a net result of triggering apoptosis and repressing cell viability. Conclusions: HCC-related differential expression of miR-34a could be etiology-based or stage-specific, and low expression of miR-34a may predict poor prognosis. This study’s findings also emphasize the role of miR-34a in apoptosis. |
format | Online Article Text |
id | pubmed-5225149 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | XIA & HE Publishing Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-52251492017-01-17 miR-34a: Multiple Opposing Targets and One Destiny in Hepatocellular Carcinoma Yacoub, Radwa Alaa Fawzy, Injie Omar Assal, Reem Amr Hosny, Karim Adel Zekri, Abdel-Rahman Nabawy Esmat, Gamal El Tayebi, Hend Mohamed Abdelaziz, Ahmed Ihab J Clin Transl Hepatol Original Article Background and Aims: The role of miR-34a in hepatocellular carcinoma (HCC) is controversial and several unresolved issues remain, including its expression pattern and relevance to tumor etiology, tumor stage and prognosis, and finally, its impact on apoptosis. Methods: miR-34a expression was assessed in hepatitis C virus (HCV)-induced non-metastatic HCC tissues by RT-Q-PCR. Huh-7 cells were transfected with miR-34a mimics and the impact of miR-34a was examined on 84 pro-apoptotic/anti-apoptotic genes using PCR array; its net effect was tested on cell viability via MTT assay. Results: miR-34a expression was up-regulated in HCC tissues. Moreover, miR-34a induced a large set of pro-apoptotic/anti-apoptotic genes, with a net result of triggering apoptosis and repressing cell viability. Conclusions: HCC-related differential expression of miR-34a could be etiology-based or stage-specific, and low expression of miR-34a may predict poor prognosis. This study’s findings also emphasize the role of miR-34a in apoptosis. XIA & HE Publishing Inc. 2016-12-27 2016-12-28 /pmc/articles/PMC5225149/ /pubmed/28097098 http://dx.doi.org/10.14218/JCTH.2016.00031 Text en © 2016 The Second Affiliated Hospital of Chongqing Medical University. Published by XIA & HE Publishing Inc. All rights reserved. http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial 4.0 Unported License, permitting all non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Article Yacoub, Radwa Alaa Fawzy, Injie Omar Assal, Reem Amr Hosny, Karim Adel Zekri, Abdel-Rahman Nabawy Esmat, Gamal El Tayebi, Hend Mohamed Abdelaziz, Ahmed Ihab miR-34a: Multiple Opposing Targets and One Destiny in Hepatocellular Carcinoma |
title | miR-34a: Multiple Opposing Targets and One Destiny in Hepatocellular Carcinoma |
title_full | miR-34a: Multiple Opposing Targets and One Destiny in Hepatocellular Carcinoma |
title_fullStr | miR-34a: Multiple Opposing Targets and One Destiny in Hepatocellular Carcinoma |
title_full_unstemmed | miR-34a: Multiple Opposing Targets and One Destiny in Hepatocellular Carcinoma |
title_short | miR-34a: Multiple Opposing Targets and One Destiny in Hepatocellular Carcinoma |
title_sort | mir-34a: multiple opposing targets and one destiny in hepatocellular carcinoma |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5225149/ https://www.ncbi.nlm.nih.gov/pubmed/28097098 http://dx.doi.org/10.14218/JCTH.2016.00031 |
work_keys_str_mv | AT yacoubradwaalaa mir34amultipleopposingtargetsandonedestinyinhepatocellularcarcinoma AT fawzyinjieomar mir34amultipleopposingtargetsandonedestinyinhepatocellularcarcinoma AT assalreemamr mir34amultipleopposingtargetsandonedestinyinhepatocellularcarcinoma AT hosnykarimadel mir34amultipleopposingtargetsandonedestinyinhepatocellularcarcinoma AT zekriabdelrahmannabawy mir34amultipleopposingtargetsandonedestinyinhepatocellularcarcinoma AT esmatgamal mir34amultipleopposingtargetsandonedestinyinhepatocellularcarcinoma AT eltayebihendmohamed mir34amultipleopposingtargetsandonedestinyinhepatocellularcarcinoma AT abdelazizahmedihab mir34amultipleopposingtargetsandonedestinyinhepatocellularcarcinoma |